• H-Aggregated NIR-II IR-1061 Liposomes Enable Synergistic Can

  2026-06-02

  Yu et al. present a targeted lipid nanosystem using H-aggregated IR-1061 to enable simultaneous NIR-II fluorescence imaging and photothermal therapy (PTT) for cancer. This approach enhances tumor targeting and therapeutic performance, providing new insight into organic fluorescent dye design for deep tissue molecular imaging applications.

• Indomethacin in Advanced Inflammation and Membrane Research

  2026-06-02

  Explore the multifaceted mechanisms of indomethacin, a nonsteroidal anti-inflammatory drug, in inflammation research and membrane signaling. This in-depth analysis reveals new insights and practical protocols for advanced biomedical investigations.

• Scenario-Driven Solutions: MG-132 (SKU A2585) in Cell Assays

  2026-06-01

  This article delivers scenario-based, evidence-backed guidance for biomedical researchers utilizing MG-132 (SKU A2585) in cell viability, apoptosis, and cell cycle arrest assays. By addressing real-world workflow challenges and integrating quantitative data, it empowers users to achieve reproducible, interpretable results in cancer research and beyond.

• M344 as a Histone Deacetylase Inhibitor in Neuroblastoma The

  2026-06-01

  The referenced study demonstrates that M344, a potent histone deacetylase inhibitor, robustly suppresses tumor growth and modulates cellular phenotypes in neuroblastoma models. These findings highlight M344's therapeutic promise and provide detailed mechanistic insights relevant to pediatric oncology research.

• (R,S)-Anatabine: Optimizing Alzheimer’s Disease Research Wor

  2026-05-31

  (R,S)-Anatabine empowers neurodegeneration researchers with targeted, reproducible workflows for soluble Aβ peptide reduction in both in vitro and in vivo Alzheimer’s models. This guide details actionable protocol enhancements, troubleshooting strategies, and practical lessons drawn from recent mechanistic advances.

• Fumagillin for Tumor Angiogenesis and Antiparasitic Research

  2026-05-30

  Fumagillin stands out as a dual-action methionine aminopeptidase-2 inhibitor, enabling precise control of angiogenesis in cancer models and providing moderate antiparasitic efficacy in aquaculture applications. This article translates the latest research and experimental protocols into actionable workflows, with troubleshooting tips to maximize reproducibility across domains.

• AI-Driven Discovery of Senolytics: Insights for Cancer Resea

  2026-05-29

  This article examines a recent study leveraging machine learning to identify novel senolytic compounds capable of selectively eliminating senescent cells. The findings highlight the scalability of AI-driven drug discovery, with broad implications for cancer and aging research.

• Targeted CRISPRi of Fabp4 in Adipocytes Ameliorates Obesity

  2026-05-29

  This study introduces a nonviral, adipocyte-targeted CRISPR interference platform to silence Fabp4, achieving significant reductions in obesity, inflammation, hepatic steatosis, and insulin resistance in murine models. The approach offers a precise, tissue-selective gene modulation strategy and highlights a new direction for metabolic disorder therapies beyond conventional drugs.

• Intracellular Protein Stability Under Extreme Osmotic Stress

  2026-05-28

  Hollembeak and Model's study offers a rigorous analysis of how mammalian cells preserve intracellular protein concentration during prolonged and severe osmotic changes. By combining quantitative phase imaging and cell volume assays, the research uncovers unexpected cellular dehydration responses and highlights fundamental aspects of macromolecular crowding, with implications for stress physiology and signaling pathway investigation.

• Resazurin Sodium Salt: Precision Fluorogenic Assays Unveiled

  2026-05-28

  Resazurin sodium salt empowers researchers to quantify cell viability and metabolism with exceptional sensitivity and dynamic range. This article delivers actionable workflow refinements, advanced protocol parameters, and expert troubleshooting—bridging cutting-edge liver fibrosis findings with practical, high-throughput assay design.

• LY2109761: TGF-β Receptor I/II Dual Inhibitor for Oncology R

  2026-05-27

  LY2109761 enables precise, selective dual inhibition of TGF-β receptor type I and II, unlocking advanced experimental control over Smad2/3-driven transcription and tumor microenvironment modulation. This guide translates high-impact findings and workflow optimizations into actionable protocols for cancer, fibrosis, and radiosensitization research.

• Injectable GelMA/QCS/Ca2+ Adhesive for Hemostasis and Infect

  2026-05-27

  The reference study introduces a blue light-triggered, injectable hemostatic adhesive based on GelMA, quaternary ammonium chitosan, and Ca2+ that rapidly seals non-compressible wounds and combats bacterial infection. This dual-function biomaterial demonstrates superior hemostatic and antibacterial performance compared to fibrin glue and traditional hydrogels, supporting its potential for emergency medicine and wound management.

• CB-5083: Applied Strategies for p97 Inhibitor Oncology Resea

  2026-05-26

  CB-5083 unlocks new precision in disrupting protein homeostasis and driving apoptosis in cancer models, thanks to its selectivity and oral bioavailability. This guide details actionable workflows, pivotal troubleshooting tips, and insights from recent ER lipid regulation research—empowering teams to maximize CB-5083’s impact across cell-based and in vivo assays.

• Ceapin-A7: Precision ER Stress Modulation for Translational

  2026-05-26

  Ceapin-A7 stands at the forefront of ER stress research, offering selective ATF6α pathway inhibition and enabling nuanced mechanistic dissection in disease models. This thought-leadership article provides translational investigators with mechanistic context, hands-on protocol guidance, and strategic insights for deploying Ceapin-A7 in advanced endoplasmic reticulum stress studies, highlighting its unique value and clinical relevance.

• Imipenem: Mechanistic Insights and Translational Impact in A

  2026-05-25

  Explore the advanced mechanism of action of Imipenem, a semisynthetic thienamycin antibiotic, and its translational relevance in antibacterial research. This article delivers unique protocol guidance and reference-driven analysis to empower experimental design beyond standard workflows.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page